Senior insider sale
Chief Financial Officer at EDGEWISE THERAPEUTICS, INC. — senior position signals high conviction
$4.61M
186.66K shares
What this filing means
CARRUTHERS R MICHAEL plans to sell 186.66K shares of EDGEWISE THERAPEUTICS, INC. valued at approximately $4.61M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001950047-25-010707
Officer· Chief Financial Officer
Since Mar 2021
186.66K
Shares to sell
$4.61M
Approx. market value
116.67K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Not Applicable
12/26/2025
116.67KTotal acquired116.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/26/2025 | Exercise of options under a registered plan Not Applicable | 116.67K | — |
| Total | 116.67K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
70K
Market value
$1.57M
11/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
116.67K
Market value
$3.04M
12/26/2025
Total
Units
186.66K
Value
$4.61M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/17/2025 | 70K | $1.57M | — | Completed |
| Planned — Approximate Date | ||||
12/26/2025 | 116.67K | $3.04M | NASDAQ | Planned |
| Total | 186.66K | $4.61M | ||